Display options
Cite
Meij V, Zuetenhorst JM, van Hillegersberg R, et al. Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol. 2005;3:75doi: 10.1186/1477-7819-3-75.
Meij, V., Zuetenhorst, J. M., van Hillegersberg, R., Kröger, R., Prevoo, W., van Coevorden, F., & Taal, B. G. (2005). Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World journal of surgical oncology, 375. https://doi.org/10.1186/1477-7819-3-75
Meij, Vincent, et al. "Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation." World journal of surgical oncology vol. 3 (2005): 75. doi: https://doi.org/10.1186/1477-7819-3-75
Meij V, Zuetenhorst JM, van Hillegersberg R, Kröger R, Prevoo W, van Coevorden F, Taal BG. Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol. 2005 Nov 17;3:75. doi: 10.1186/1477-7819-3-75. PMID: 16293186; PMCID: PMC1325231.
Copy Download .nbib Format: NLM
Share it on

World J Surg Oncol. 2005 Nov 17;3:75. doi: 10.1186/1477-7819-3-75.

Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation.

World journal of surgical oncology

Vincent Meij, Johanna M Zuetenhorst, Richard van Hillegersberg, Robert Kröger, Warner Prevoo, Frits van Coevorden, Babs G Taal

Affiliations

  1. Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. [email protected]

PMID: 16293186 PMCID: PMC1325231 DOI: 10.1186/1477-7819-3-75

Abstract

BACKGROUND: Hepatic metastases of carcinoid tumors cause incapacitating symptoms, but are usually diffuse and therefore unresectable. In this article we evaluate our experiences with local treatment techniques in the management of carcinoid patients with hepatic metastases and failing systemic treatment.

METHODS: Fifteen consecutive carcinoid patients (11 men and 4 women; median age 60 years; range 45-71 years) were treated with either hepatic artery embolization (HAE) with Ivalon particles or radiofrequency ablation (RFA) (percutaneously or intra-operatively). Follow-up evaluation was performed by CT scan and 24-hours urinary 5-HIAA excretions.

RESULTS: A total of 18 HAE's was performed in 13 patients, while 10 lesions in 3 patients were treated with RFA. Median follow-up was 12.5 months (2 - 25 months). Median duration of symptoms was 22 months (8 - 193 months). Median overall decrease of 5-HIAA excretion 2 months after HAE was 32% with tumor regression on CT-scan in 4 patients (30%) and improvement of symptoms with a median duration of 15 months in 3 of them (23%). Embolization led to fatal hepatic failure in one patient. The 3 patients treated with RFA showed a decrease of urinary 5-HIAA values of 34, 81 and 93% respectively, with tumor regression in all of them. Improvement of symptoms was reported in 2 patients up to 25 months.

CONCLUSION: Liver embolization performed late in the clinical course had limited effect on symptoms and biochemical and radiological parameters. First experiences with RFA are favorable and might encourage to apply RFA more widely in metastatic carcinoid.

References

  1. Eur J Cancer. 1992;28(1):75-8 - PubMed
  2. J Surg Res. 2001 Jan;95(1):8-12 - PubMed
  3. Am J Surg. 2001 Dec;182(6):552-7 - PubMed
  4. Arch Surg. 2002 Apr;137(4):422-6; discussion 427 - PubMed
  5. World J Surg. 2002 Aug;26(8):985-90 - PubMed
  6. World J Surg. 2002 Aug;26(8):1052-6 - PubMed
  7. Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1157-64 - PubMed
  8. Cancer. 1998 Dec 1;83(11):2293-301 - PubMed
  9. Lancet. 1998 Sep 5;352(9130):799-805 - PubMed
  10. AJR Am J Roentgenol. 1998 Feb;170(2):339-44 - PubMed
  11. Surgery. 1997 Dec;122(6):1147-54; discussion 1154-5 - PubMed
  12. J Clin Oncol. 1996 Jun;14(6):1829-38 - PubMed
  13. Cancer. 1993 Apr 15;71(8):2624-30 - PubMed
  14. Am J Surg. 1995 Jan;169(1):36-42; discussion 42-3 - PubMed
  15. Radiology. 1985 Jun;155(3):623-6 - PubMed
  16. N Engl J Med. 1986 Sep 11;315(11):663-6 - PubMed
  17. AJR Am J Roentgenol. 1986 Jul;147(1):149-54 - PubMed
  18. Am J Clin Oncol. 2000 Aug;23(4):412-5 - PubMed
  19. J Gastrointest Surg. 2002 Sep-Oct;6(5):664-70 - PubMed

Publication Types